Biotech

All Articles

Ventyx's last hope for inflammatory med ends in Crohn's failing

.Ventyx Biosciences' Crohn's disease medicine performed certainly not assist patients obtain remissi...

Cognition's phase 2 radiate data stain Alzheimer's possibility

.Cognition Therapies' period 2 SHINE trial has taken a number of the luster off the Alzheimer's illn...

BMS centers bispecific months after filing to work stage 3 test

.Bristol Myers Squibb has actually possessed a whiplash change of heart on its own BCMA bispecific T...

Charles Baum consumes Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who supervised Mirati Therapies' $ 5.8 billion sale to Bristol Myers Squ...

Asarina to shut after initiatives to partner Tourette's medication neglect

.After connecting to greater than 200 providers to partner a Tourette disorder treatment that presen...

Novartis markers $150M upfront bispecifics deal with Dren Biography

.Novartis has actually possessed some misfortune with bispecific antitoxins over the last, but evalu...

AstraZeneca vegetations an EGFR tree along with Pinetree bargain worth $45M

.Pinetree Therapies will help AstraZeneca vegetation some plants in its pipe with a brand-new treaty...

GRO rounds up $60M series B to take gout pain treatment into center

.GRO Biosciences has actually finished the full week along with an extra $60.3 thousand in the finan...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava loses CEO

.Invite to this week's Chutes &amp Ladders, our summary of notable management hirings, shootings and...